Endothelial dysfunction after repeated Chlamydia pneumoniae infection in apolipoprotein E-knockout mice.
about
Effect of clarithromycin treatment on Chlamydia pneumoniae in vascular tissue of patients with coronary artery disease: a randomized, double-blind, placebo-controlled trialEndothelial dysfunction and cardiovascular disease.Chlamydia pneumoniae--an infectious risk factor for atherosclerosis?Infection with Chlamydia pneumoniae as a cause of coronary heart disease: the hypothesis is still untestedInfection and Atherosclerosis DevelopmentPossibilities for therapeutic interventions in disrupting Chlamydophila pneumoniae involvement in atherosclerosis.C. pneumoniae disrupts eNOS trafficking and impairs NO production in human aortic endothelial cells.Endothelial cell death and intimal foam cell accumulation in the coronary artery of infected hypercholesterolemic minipigs.Infection-induced coronary dysfunction and systemic inflammation in piglets are dampened in hypercholesterolemic milieu.Elevated infection parameters and infection symptoms predict an acute coronary event.Maternal serum Chlamydia pneumoniae antibodies and CRP levels in women with preeclampsia and gestational hypertension.Early impairment of coronary flow reserve is not associated with Chlamydia pneumoniae antibodies.NK cell compartment in patients with coronary heart diseaseRespiratory infection recurrence and passive smoking in early atherosclerosis in children and adolescents with type 1 diabetes.Endothelial dysfunction in patients with asthma: the role of polymorphisms of ACE and endothelial NOS genes.HLA, infections and inflammation in early stages of atherosclerosis in children with type 1 diabetes.Soy protein diet and exercise training increase relative bone volume and enhance bone microarchitecture in a mouse model of uremia.Chlamydia pneumoniae and Cardiovascular Disease.Chlamydia pneumoniaeand atherosclerosisResidual adverse changes in arterial endothelial function and LDL oxidation after a mild systemic inflammation induced by influenza vaccination
P2860
Q33752851-1297505A-77AD-43E1-A464-547EEFE8DE46Q35156621-8922BDAE-7281-48FD-B4F8-86742D949ED6Q35701591-4F8B1A35-CC7A-48C5-8E37-6D7C02A850BAQ35821202-D755ECF2-CE1B-4639-B480-F6D4EEE699CFQ35915081-8C9F9F89-9027-42F3-9B56-B0DFB06EE611Q37775097-F0FB0185-63B1-4E93-B381-40B2A0C7741DQ37843761-33151608-B65D-4676-AF7B-A4D359EADE48Q37846710-84EB05A4-7F55-49D5-80F5-6E60DF352454Q37851309-7FDB45B8-8E6F-4143-8E22-7EB2647823EAQ37855841-9A33C8B8-D3C5-4968-9292-43EBD4E84E68Q37857465-C33B6EC2-2F71-42FE-ACBD-82165E741766Q37871079-9AD45CBE-6E80-4225-8692-752C9B892BDAQ42772357-51FC3D83-2355-4EC7-82BD-C09E8B20E099Q43534858-E3D956DC-0B95-4C67-BFFF-86F100A705DBQ47681488-668BAACD-D7F2-4672-AAFB-AB40E4241B39Q47734445-B474E315-1C52-4663-8622-8E754A75591BQ51455158-183176F0-2F6B-4A44-9C2C-37D0E8BF60CFQ51726841-61968293-A209-47E7-8494-3F138DBC8BF7Q54063686-1E6EA5E2-349D-4EE8-A332-3676D21CCD73Q58136255-60830223-7E76-4CCC-8A01-4B3CA7CF3894
P2860
Endothelial dysfunction after repeated Chlamydia pneumoniae infection in apolipoprotein E-knockout mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2000
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Endothelial dysfunction after ...... polipoprotein E-knockout mice.
@en
Endothelial dysfunction after ...... polipoprotein E-knockout mice.
@nl
type
label
Endothelial dysfunction after ...... polipoprotein E-knockout mice.
@en
Endothelial dysfunction after ...... polipoprotein E-knockout mice.
@nl
prefLabel
Endothelial dysfunction after ...... polipoprotein E-knockout mice.
@en
Endothelial dysfunction after ...... polipoprotein E-knockout mice.
@nl
P2093
P1433
P1476
Endothelial dysfunction after ...... polipoprotein E-knockout mice.
@en
P2093
Johansson L
Paakkari I
Wadström T
P304
P356
10.1161/01.CIR.102.9.1039
P407
P577
2000-08-01T00:00:00Z